Entera Bio Performance
| ENTXWDelisted Stock | USD 0 0.00 0.00% |
The firm shows a Beta (market volatility) of 6.05, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Entera Bio will likely underperform. Entera Bio right now shows a risk of 0.0%. Please confirm Entera Bio treynor ratio and the relationship between the potential upside and rate of daily change , to decide if Entera Bio will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Entera Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Entera Bio is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 25 M | |
| Free Cash Flow | -12.5 M |
Entera |
Entera Bio Relative Risk vs. Return Landscape
If you would invest 0.12 in Entera Bio on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Entera Bio or generate 0.0% return on investment over 90 days. Entera Bio is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Entera, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Entera Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Entera Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Entera Bio, and traders can use it to determine the average amount a Entera Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ENTXW |
Based on monthly moving average Entera Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entera Bio by adding Entera Bio to a well-diversified portfolio.
Entera Bio Fundamentals Growth
Entera Stock prices reflect investors' perceptions of the future prospects and financial health of Entera Bio, and Entera Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Entera Stock performance.
| Revenue | 134 K | |||
| EBITDA | (13.02 M) | |||
| Total Debt | 91 K | |||
| Cash Flow From Operations | (12.5 M) | |||
| Total Asset | 13.13 M | |||
| Retained Earnings | (95.5 M) | |||
About Entera Bio Performance
Evaluating Entera Bio's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Entera Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Entera Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Entera Bio performance evaluation
Checking the ongoing alerts about Entera Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Entera Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Entera Bio is not yet fully synchronised with the market data | |
| Entera Bio has some characteristics of a very speculative penny stock | |
| Entera Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 134 K. Net Loss for the year was (13.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Entera Bio generates negative cash flow from operations |
- Analyzing Entera Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Entera Bio's stock is overvalued or undervalued compared to its peers.
- Examining Entera Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Entera Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Entera Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Entera Bio's stock. These opinions can provide insight into Entera Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Entera Stock
If you are still planning to invest in Entera Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Entera Bio's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |